| 发明名称 |
COMBINATION THERAPY WITH VOLASERTIB |
| 摘要 |
<p>The present invention relates to the use of Volasertib or a salt or a hydrate thereof for treating patients suffering from acute myeloid leukemia(AML) comprising administering a high dose of Volasertib in combination with fludarabine, cytarabine and Granulocyte colony- stimulating factor(GCSF) or in combination with fludarabine cytarabine , GCSF and a daunorubicin citrate liposome injection.</p> |
| 申请公布号 |
IN3075DEN2015(A) |
申请公布日期 |
2015.10.02 |
| 申请号 |
IN2015DE03075 |
申请日期 |
2015.04.13 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
TAUBE, TILLMANN, |
| 分类号 |
A61K38/19;A61K31/519;A61K31/704 |
主分类号 |
A61K38/19 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
